{"PRIDE": {"PXD017469": {"accession": "PXD017469", "title": "Characterization of signaling pathways associated with pancreatic beta-cell adaptive flexibility in compensation of obesity-linked diabetes in db/db miceCharacterization of signaling pathways associated with pancreatic \u03b2-cell adaptive flexibility in compensation of obesity-linked diabetes in db/db mice", "additionalAttributes": [{"@type": "CvParam", "cvLabel": "PRIDE", "accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD017469"}], "projectDescription": "To characterize the signaling mechanisms underlying beta-cell dysfunction in db/db mice and their return to a more \u201cnormal\u201d beta-cell phenotype, we applied a mass spectrometry-based quantitative phosphophoproteomics and sialiomics(sialylated N-linked glycopeptides) approach to normal and db/db beta-cells from hyperglycemic and euglycemic environments.", "sampleProcessingProtocol": "Quantitative phosphoproteomics and sialiomics (sialylated N-linked glycopeptides) was performed on pancreatic islets derived from obese diabetic C57BL/6Jdb/db mice and matching wild-type controls using TMT labeling combined with sequential TiO2 enrichment of phosphopeptides and formerly sialylated N-linked glycopeptides.", "dataProcessingProtocol": "The raw MS data sets were processed for protein identification using the MS-GF+ (v9979, 07/16/2014) combined with the MASIC pipeline with a peptide mass tolerance of 20 ppm, reporter ion m/z tolerance half width of 2 mDa, and a false discovery rate (FDR) of 1% for proteins and peptides. All peak lists were searched against the UniProtKB/Swiss-Prot database (2013_06, 16,613 entries) of mouse sequences with decoy using the parameters as follows: enzyme, trypsin; maximum missed cleavages, 2; fixed modification, carbamidomethylation (C), iTRAQ or TMT tags (K, peptide N-termini); variable modifications, oxidation (M), phosphorylation (S,T,Y), and deamidation (N). For sialylated peptides, the Asn-X(except proline)-Ser/Thr/Cys consensus sequence is required to be considered a deglycopeptide.", "projectTags": [], "keywords": ["Beta-cells", "Obesity", "Islets", "Diabetes"], "doi": "10.6019/PXD017469", "submissionType": "COMPLETE", "license": "Creative Commons Public Domain (CC0)", "submissionDate": "2020-03-12", "publicationDate": "2020-05-19", "submitters": [{"title": "Dr", "affiliation": "University of Southern Denmark", "email": "taewookk@bmb.sdu.dk", "country": "Denmark", "orcid": "", "name": "Taewook Kang", "id": "71380121"}], "labPIs": [{"title": "Dr", "affiliation": "Protein research group, Department of Biochemistry and Molecular Biology, University of Southern Denmark, DK-5230 Odense M, Denmark.", "email": "mrl@bmb.sdu.dk", "country": "", "orcid": "", "name": "Martin R. Larsen", "id": "184880100"}], "affiliations": ["University of Southern Denmark", "Protein research group, Department of Biochemistry and Molecular Biology, University of Southern Denmark, DK-5230 Odense M, Denmark."], "instruments": [{"@type": "CvParam", "cvLabel": "MS", "accession": "MS:1002732", "name": "Orbitrap Fusion Lumos"}, {"@type": "CvParam", "cvLabel": "MS", "accession": "MS:1002523", "name": "Q Exactive HF"}], "softwares": [{"@type": "CvParam", "cvLabel": "MS", "accession": "MS:1000531", "name": "MS-GF+ Beta (v10089)"}], "quantificationMethods": [{"@type": "CvParam", "cvLabel": "PRIDE", "accession": "PRIDE:0000314", "name": "TMT"}], "countries": [], "sampleAttributes": [], "organisms": [{"@type": "CvParam", "cvLabel": "NEWT", "accession": "10090", "name": "Mus musculus (mouse)"}], "organismParts": [{"@type": "CvParam", "cvLabel": "BTO", "accession": "BTO:0005813", "name": "Pancreatic islet cell"}, {"@type": "CvParam", "cvLabel": "CL", "accession": "UBERON:0000006", "name": "Islet of langerhans"}], "diseases": [{"@type": "CvParam", "cvLabel": "DOID", "accession": "DOID:9352", "name": "Type 2 diabetes mellitus"}], "references": [{"referenceLine": "Kang T, Boland BB, Jensen P, Alarcon C, Nawrocki A, Grimsby JS, Rhodes CJ, Larsen MR. Characterization of signaling pathways associated with pancreatic \u03b2-cell adaptive flexibility in compensation of obesity-linked diabetes in db/db mice.  Mol Cell Proteomics. 2020", "doi": "10.1074/mcp.ra119.001882", "pubmedId": 32265294, "id": 32265294}], "identifiedPTMStrings": [{"@type": "CvParam", "cvLabel": "MOD", "accession": "MOD:01720", "name": "TMT6plex-126 reporter+balance reagent acylated residue"}, {"@type": "CvParam", "cvLabel": "MOD", "accession": "MOD:00425", "name": "monohydroxylated residue"}, {"@type": "CvParam", "cvLabel": "MOD", "accession": "MOD:00696", "name": "phosphorylated residue"}, {"@type": "CvParam", "cvLabel": "MS", "accession": "MS:1001460", "name": "unknown modification"}, {"@type": "CvParam", "cvLabel": "UNIMOD", "accession": "UNIMOD:21", "name": "Phospho"}, {"@type": "CvParam", "cvLabel": "MOD", "accession": "MOD:00397", "name": "iodoacetamide derivatized residue"}, {"@type": "CvParam", "cvLabel": "UNIMOD", "accession": "UNIMOD:7", "name": "Deamidated"}, {"@type": "CvParam", "cvLabel": "MOD", "accession": "MOD:00400", "name": "deamidated residue"}, {"@type": "CvParam", "cvLabel": "UNIMOD", "accession": "UNIMOD:4", "name": "Carbamidomethyl"}, {"@type": "CvParam", "cvLabel": "UNIMOD", "accession": "UNIMOD:35", "name": "Oxidation"}], "_links": {"self": {"href": "https://www.ebi.ac.uk/pride/ws/archive/v2/projects/PXD017469"}, "files": {"href": "https://www.ebi.ac.uk/pride/ws/archive/v2/projects/PXD017469/files"}, "datasetFtpUrl": {"href": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/05/PXD017469"}}, "peptides": null, "protein": ["PXD017469:121080:E9PV96:[MS:1001460]M[UNIMOD:35]PHLNSTIFR", "PXD017469:121073:E9PV96:FY[UNIMOD:21]WTTVVSHS[UNIMOD:21]Y[UNIMOD:21]C[UNIMOD:4]EHMAIVKLAAEDVHVNK", "PXD017469:121083:E9PV96:[MS:1001460]M[UNIMOD:35]PHLNSTIFR"], "summary": "To characterize the signaling mechanisms underlying beta-cell dysfunction in db/db mice and their return to a more \u201cnormal\u201d beta-cell phenotype, we applied a mass spectrometry-based quantitative phosphophoproteomics and sialiomics(sialylated N-linked glycopeptides) approach to normal and db/db beta-cells from hyperglycemic and euglycemic environments.", "website": "http://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD017469"}}}